363 related articles for article (PubMed ID: 7492761)
1. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin enhances the alpha IIb beta 3-dependent adhesion of megakaryocytic cells to fibrinogen or fibronectin through PI 3 kinase.
Zauli G; Bassini A; Vitale M; Gibellini D; Celeghini C; Caramelli E; Pierpaoli S; Guidotti L; Capitani S
Blood; 1997 Feb; 89(3):883-95. PubMed ID: 9028319
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.
Campus F; Lova P; Bertoni A; Sinigaglia F; Balduini C; Torti M
J Biol Chem; 2005 Jul; 280(26):24386-95. PubMed ID: 15863506
[TBL] [Abstract][Full Text] [Related]
4. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin modulates platelet activation in vitro through protein-tyrosine phosphorylation.
Kubota Y; Arai T; Tanaka T; Yamaoka G; Kiuchi H; Kajikawa T; Kawanishi K; Ohnishi H; Yamaguchi M; Takahara J; Irino S
Stem Cells; 1996 Jul; 14(4):439-44. PubMed ID: 8843545
[TBL] [Abstract][Full Text] [Related]
6. Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.
Luoh SM; Stefanich E; Solar G; Steinmetz H; Lipari T; Pestina TI; Jackson CW; de Sauvage FJ
Mol Cell Biol; 2000 Jan; 20(2):507-15. PubMed ID: 10611229
[TBL] [Abstract][Full Text] [Related]
7. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates.
Harker LA; Marzec UM; Hunt P; Kelly AB; Tomer A; Cheung E; Hanson SR; Stead RB
Blood; 1996 Jul; 88(2):511-21. PubMed ID: 8695799
[TBL] [Abstract][Full Text] [Related]
8. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin potentiates activation of human platelets in association with JAK2 and TYK2 phosphorylation.
Rodríguez-Liñares B; Watson SP
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):93-8. PubMed ID: 8645238
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.
Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K
Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin.
Ballmaier M; Schulze H; Strauss G; Cherkaoui K; Wittner N; Lynen S; Wolters S; Bogenberger J; Welte K
Blood; 1997 Jul; 90(2):612-9. PubMed ID: 9226161
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
[TBL] [Abstract][Full Text] [Related]
13. A novel thrombopoietin signaling defect in polycythemia vera platelets.
Moliterno AR; Siebel KE; Sun AY; Hankins WD; Spivak JL
Stem Cells; 1998; 16 Suppl 2():185-92. PubMed ID: 11012190
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets.
Miyakawa Y; Oda A; Druker BJ; Miyazaki H; Handa M; Ohashi H; Ikeda Y
Blood; 1996 Jan; 87(2):439-46. PubMed ID: 8555464
[TBL] [Abstract][Full Text] [Related]
15. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.
Ballmaier M; Germeshausen M; Schulze H; Cherkaoui K; Lang S; Gaudig A; Krukemeier S; Eilers M; Strauss G; Welte K
Blood; 2001 Jan; 97(1):139-46. PubMed ID: 11133753
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin amplifies ADP-induced HSP27 phosphorylation in human platelets: importance of pre-treatment.
Cuong NT; Doi T; Matsushima-Nishiwaki R; Akamatsu S; Kuroyanagi G; Kondo A; Mizutani J; Wada I; Otsuka T; Tokuda H; Kozawa O; Ogura S
Int J Mol Med; 2013 Jun; 31(6):1291-7. PubMed ID: 23588296
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro.
Ezumi Y; Takayama H; Okuma M
FEBS Lett; 1995 Oct; 374(1):48-52. PubMed ID: 7589510
[TBL] [Abstract][Full Text] [Related]
18. Relative reactivity of platelets from thrombopoietin- and interleukin-6-treated dogs.
Peng J; Friese P; Wolf RF; Harrison P; Downs T; Lok S; Dale GL; Burstein SA
Blood; 1996 May; 87(10):4158-63. PubMed ID: 8639774
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis.
Rojnuckarin P; Drachman JG; Kaushansky K
Blood; 1999 Aug; 94(4):1273-82. PubMed ID: 10438715
[TBL] [Abstract][Full Text] [Related]
20. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
Quentmeier H; Zaborski M; Drexler HG
Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
